We studied the ability of lymphocytes from type I (insulin-dependent) diabetic patients to adhere to murine p-cells. Lymphocytes from 17 recent-onset type I diabetic subjects ( 6 mo) displayed enhanced ability to form rosettes with RINm5F cells (P < .001) compared with lymphocytes from 27 healthy subjects forming background rosettes, whereas the number of RIN cytoadherent lymphocytes was unimpaired in 12 type II (non-insulin-dependent) diabetic subjects. This phenomenon tended to decline in 21 subjects with long-standing diabetes ( 1 yr) who taken as a group presented a normal number of RIN rosetting lymphocytes. The islet specificity of these diabetic rosettes was confirmed because, compared with controls, lymphocytes from recent-onset type I diabetic subjects also displayed a greater intensity of adherence to normal mouse islets but not to unrelated K562 and TS cell lines. As demonstrated by indirect immunofluorescence studies, these diabetic rosettes contained 54% of T-lymphocytes (OKT3 + , OKT4 + , or OKT8+), whereas only 20% of T-lymphocytes were found in background rosettes. The high percentage (66%) of la + cells found in diabetic rosettes suggests that at least some of the cytoadherent T-lymphocytes from recent-onset type I diabetic subjects are activated. Natural killer (NK) cells do not seem to be the major cell type implicated in this phenomenon, because Leu 11 + cells were less represented in diabetic rosettes (25%) than in background rosettes (53%). Moreover, the NK lytic activity of lymphocytes from 12 recent-onset type I diabetic subjects was lower than that of 12 control subjects (21.6 ± 2.8 vs. 31.2 ± 3.3, P < .02) and even inversely correlated to the number of rosetting lymphocytes (r = -.8, P < .005). These 
M uch converging evidence suggests that type I (insulin-dependent) diabetes is a genetically programmed autoimmune disease (1) . All the data accumulated during the past decade concerning autoimmunity in type I diabetes are now reinforced by the increased remission rate observed in recent-onset diabetic subjects treated with immunosuppressive drugs, e.g., cyclosporin A (2-4), azathioprine (5) , and ciamexone (6) . Still, much work is needed to analyze the pathogenesis of the disease more precisely to allow more specific immunotherapy.
Intense interest has focused on humoral immunity since the discovery of islet cell autoantibodies (7, 8) . However, despite evidence that islet cell antibodies from diabetic patients can bind to islet cells in vivo (9) and are able to lyse p-cells (10) or alter insulin release in vitro (11, 12) and in vivo (13, 14) , it is unlikely that they represent the major determinant of pcell destruction (15) . In fact, there are reasons to believe that activated T-lymphocytes, which are able to lyse p-cells (16) and to alter insulin release in vitro (17) , and perhaps natural killer (NK) cells (18) or macrophages (19) are deeply involved in p-cell aggression. This hypothesis of the prominence of cellular immunity over humoral immunity has been well supported in the BB/W rat by experiments that show concanavalin A-activated lymphocytes can transfer diabetes (20) ; however, this remains to be confirmed in human diabetes, because in vitro studies of cell-mediated immunity are still limited in number.
We present evidence for specific in vitro binding of Tlymphocytes from diabetic patients to murine tumoral or normal p-cells. This rosette formation was previously described 10 yr ago by Huang and Maclaren (21) but was not further investigated. Our data suggest that in vitro binding of diabetic lymphocytes to p-cells could represent a marker of cellular autoimmunity in type I diabetes.
MATERIALS AND METHODS
Subjects. Thirty-eight type I diabetic patients were evaluated. No patient was in the "honeymoon" or transient remission phase. Among these subjects, two groups were distinguished: a subgroup of 17 patients (9 males, 8 females; mean age 29.8 ± 13 yr, range 12-42) with a mean disease duration of 0.4 ± 0.8 mo (range 0-3) and a subgroup of 21 patients (10 males, 11 females; mean age 30.2 ± 10 yr, range 15-51) with a mean disease duration of 10.4 ± 7 yr (range 1-25). Twelve type II diabetic patients (4 males, 8 females; mean age 54.3 ± 15 yr, range 16-65) with a mean disease duration of 9.7 ± 7.2 yr (range 0. [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] were also evaluated. Twenty-seven healthy volunteers of mean age 30.2 ± 5 yr (range 25-36) were used as control subjects. All of the healthy subjects had normal fasting blood glucose levels and no family history of diabetes or other autoimmune diseases. Lymphocyte preparation. Peripheral venous blood was collected in heparinized tubes. After centrifugation, the serum was removed and buffy coat cells were diluted in Hanks' balanced salt solution containing 2% heat-inactivated fetal calf serum (FCS; Boehringer France, Meylan, France in RPMI-10% FCS. Islets were freshly isolated from pancreases of BALB/c mice by collagenase digestion, as previously described (25) . Rosette formation. The method used for rosette formation is derived from a technique previously described by Huang and Maclaren (21) . RINm5F cells were treated with trypsin-EDTA as described above and incubated in RPMI-10% FCS (culture medium, CM) for 2 h at 37°C in 5% CO 2 humidified atmosphere to allow reappearance of cell surface antigens that might have been digested by trypsin. These target cells were then irradiated at 4000 rads and seeded in 5-ml polypropylene culture tubes (Sarstedt, Rommelsdorf, Numbrecht, FRG). In each tube, 200,000 insulinoma cells in 1 ml CM were mixed with lymphocytes from diabetic or control subjects (1.5 x 10 6 lymphocytes in 1 ml CM). Tubes were kept at 37°C in 5% CO 2 atmosphere for 24, 48, or 72 h. Rosette counting was performed as follows: 1.75 ml of CM were carefully removed from each tube, and cells were gently resuspended in the remaining 250 jil of medium. An aliquot of 20 |xl of the cell suspension was laid in Malassez counting chambers, and lymphocytes adhering to insulinoma cells were counted. At least 200 insulinoma cells were counted. Insulinoma cells with adhesion of one or more lymphocytes were considered positive for cytoadherence. Results are given as the total number of rosetting lymphocytes among the 1.5 x 10 6 lymphocytes initially seeded in each tube. In some instances, RIN rosettes were also counted.
In each experiment, diabetic patients were tested in triplicate along with at least two control subjects also in triplicate. The intra-assay variability never exceeded 15%. Three individuals of each group (diabetic or control) were tested in three different experiments to evaluate interassay variability. This interassay variability did not exceed 15%. Preparation of rosettes with K562 cells or TS cells was performed in exactly the same conditions as with insulinoma cells.
For rosettes with mice islets, 10 islets were mixed with 200,000 lymphocytes from diabetic or control subjects in 200 ixl RPMI-10% FCS in 96 flat-bottomed-well microplates (Nunc). The culture plates were then incubated in a CO 2 -enriched atmosphere for 24, 48, or 72 h. Intensity of cytoadherence was evaluated at x400 under an inverted microscope. Phenotypic characterization of rosetting cells. To phenotype lymphocytes cytoadherent to insulinoma cells, rosette preparation was carried out as follows: after irradiation, 400,000 RIN cells were seeded on 18 x 18-mm coverslips placed in 35 x 10-mm petri dishes (Falcon) in 2 ml CM. After 24 h incubation, insulinoma cells were adherent. One milliliter of lymphocyte suspension (3 x 10 5 cells/ml) of either control or diabetic subjects was then added to the petri dishes for another 48-h incubation. The coverslips were then carefully washed with warm PBS so that the nonadhering lymphocytes were removed while insulinoma cells with cytoadherent lymphocytes remained. These rosettes were fixed for 10 min in PBS containing 2% (wt/vol) paraformaldehyde. The coverslips were then covered with 50 (xl of diluted monoclonal antibodies ( Cr, i.e., in the absence of effector cells, never exceeded 15% of the MR. After 6 h incubation at 37°C in CO 2 -enriched atmosphere, 100 |xl of supernatant were collected in each well and counted for radioactivity in an LKB 7-counter. The standard deviation of the triplicate of each individual never exceeded 7%. Specific cytotoxicity was calculated from the formula: total % lysis = test counts per minute (cpm) -SR cpm/MR cpm -SR cpm.
Detection of islet cell autoantibodies in diabetic sera and statistical analysis. To detect the presence of islet cell autoantibodies (ICAs) in sera from diabetic patients, an enzymelinked immunoabsorbent assay (ICA-ELISA) was carried out as previously described (26) using dessicated RINm5F cells as targets. All data are presented as means ± SE, and P values were determined with Student's unpaired t test. Correlation was assessed by linear regression analysis.
RESULTS
Rosette formation. After 48 h incubation of lymphocytes from recent-onset diabetic patients with RIN cells, a phenomenon of cytoadherence on RIN cells of part of the lymphocytes could be observed (Fig. 1) . Figure 2 shows that the total number of lymphocytes forming rosettes with RIN cells was significantly greater (P < .001) in the recent-onset diabetic group (15,461 ± 653, n = 17) than were the background rosettes in the control group (9039 ± 352, n -27). In this group of recent-onset diabetic subjects, 14 (82%) of 17 patients were considered positive for cytoadherence because they displayed several rosetting lymphocytes exceeding mean value ± 2SD of the control group. No difference was seen between the type II (non-insulin-dependent) diabetic (9166 ± 365, n = 12) and the control group. Moreover, Table 1 suggests that, in the recent-onset diabetic group, both the number of rosettes and the number of cytoadherent cells per rosettes were increased compared with control subjects. Specificity of rosette formations. To check the specificity to p-cell antigens of the rosetting lymphocytes in the type I diabetic group, the same experiments were performed on freshly isolated mouse islets, on K562 cells, and on TS cells. Figure 3 shows the intensity of cytoadherence on mouse islets of lymphocytes from a recent-onset diabetic patient and a normal subject. All of the 14 subjects who were considered positive on RIN cells displayed a higher intensity of cytoadherence on mouse islets compared with normal subjects.
In contrast, Fig. 4 shows that no difference could be seen between recent-onset diabetic (n = 10) and control (n = 10) subjects concerning the number of cytoadherent lymphocytes on TS cells (13,804 ± 1354 vs. 13,710 ± 1188, respectively). On the K562 cell line, lymphocytes from the recent-onset diabetic group (n = 14) showed a tendency toward decreased cytoadherence compared with lymphocytes from the control group (n = 15; 37,522 ± 3846 vs. 48,170 ± 5594, respectively; P = .065). To confirm this result, NK activity of these recent-onset diabetic subjects ) from diabetic and control subjects were incubated with 2 x 10 5 RIN cells for 24, 48, and 72 h before counting of cytoadherent lymphocytes. *P < .005 and f P = .001 for diabetic vs. control subjects. was compared with that of control lymphocytes in a 51 Crrelease assay on the K562 cell line. Figure 5 shows that, at an effector/target ratio of 25:1, mean NK activity in the diabetic group (21.6 ± 2.8%, n = 12) was significantly lower than in the control group (n = 12; 31.2 ± 3.3%; P < .02). This lower NK activity in the diabetic group was also observed at lower effector/target ratios (E/T = 12.5:1, 12.5 ± 2 vs. 20.5 ± 2.5, P < .05, and E/T = 6.25:1, 6.3 ± 1.4 vs. 11.1 ± 1.6, P < .05).
An inverse correlation was found in the recent-onset diabetic group between NK activity and cytoadherence on RIN cells (n = 10, r = -. 8 , P < .005; Fig. 6 ). Kinetics of rosette formation. To investigate the kinetics of rosette formation, lymphocytes adherent to RIN cells were counted after 24, 48, and 72 h of incubation. The optimum number of rosetting lymphocytes was obtained after 48 h of incubation in the recent-onset diabetic group as well as in the control group ( Table 2) . The difference between the diabetic and control groups concerning number of rosetting lymphocytes was significant at all days tested, with a maximum significance after the 48-h incubation period (P < .001). Evolution of cytoadherent lymphocytes during the course of the disease. The mean number of rosetting lymphocytes in the group of diabetic patients with long-standing disease (n = 21) was 10,129 ± 742, which was not significantly different from the mean value of the control group. Figure 7 suggests a progressive decrease in the number of rosetting lymphocytes during the course of diabetes, although some patients with long disease duration still display many rosetting lymphocytes. Phenotyping of the cytoadherent cells by immunofluorescence. Lymphocytes cytoadherent to RIN cells from three recent-onset type I diabetic patients and three normal subjects were phenotyped via different monoclonal antibodies. The three diabetic patients were all positive for the diabetic rosettes test; i.e., they all had several RIN cytoadherent lymphocytes exceeding mean value of control ± 2SD. Cytoadherent cells in the type I diabetic group were mainly T3 + (mature T-lymphocytes; 54 ± 2%) and la + (activated lymphocytes; 66 ± 10%; Fig. 8 ) expressing either T4 antigen (43 ± 8%) or T8 antigen (27 ± 2%). Only a few Leu 11 + cells were seen in this group (25 ± 9%). On the contrary, in the control group, background rosettes were mainly composed of Leu 11 + cells (53 ± 8%) and a few T3+ (20 ± 4%) and la + (25 ± 8%) cells (Table 3) . Detection of anti-islet cell antibodies by ELISA. With the ELISA, ICAs were detected in sera from 8 (47%) of the 17 recent-onset type I diabetic subjects because their sera led to an optical density higher than mean ± 2SD of control samples (pooled from 25 healthy subjects). No correlation was found between presence (or absence) of ICAs and presence (or absence) of diabetic rosettes; these diabetic rosettes were equally detected in ICA + and ICA^ recent-onset diabetic subjects (6 and 8 of 17 patients, respectively).
DISCUSSION
Our data suggest that lymphocytes from recent-onset type I diabetic patients display an enhanced ability to adhere to (3-cells compared with lymphocytes from control subjects, which leads to the formation of diabetic rosettes. This phenomenon seems to be specific to p-cell antigens, because the increased percentage of rosetting lymphocytes in the recent-onset type I diabetic group was observed with rat insulinoma cells (RINm5F) and with mouse islets but not with unrelated cell lines such as TS or K562. The absence of such diabetic rosettes with lymphocytes from type II diabetic patients confirms the specificity of the phenomenon for type I diabetes. Moreover, in our study this phenomenon seems to climax at the onset of diabetes and progressively declines during the course of the disease. This increased cytoadherence of lymphocytes from 82% of recent-onset type I diabetic subjects on fi-cells, although only 47% of the same patients had antibodies to islet cells, could reveal the existence of cellular autoimmunity and is in accordance with the finding of Huang and Maclaren (21) a decade ago. The anti-3-cell process probably declines after the onset of diabetes with progressive loss of (3-cell mass, which would be consistent with the description of the kinetics of RIN rosette formation during the disease and with the findings of Jackson et al. (27) , who described an increased percentage of activated T-lymphocytes (la + ) at the onset of type I diabetes, which progressively declines further.
Another argument for T-lymphocyte implication in the formation of diabetic rosettes is given by our immunofluorescence studies revealing the presence of IOT3 + cells (mature T-lymphocytes), whereas in background rosette, only few IOT3 + cells were observed. Moreover, la-bearing cells were highly involved in diabetic rosettes and poorly involved in background rosettes. The fact that in diabetic rosettes the percentage of la + cells (66%) was higher than the percentage of T3 + cells (54%) could be explained by cytoadherence of T3~ cells bearing the la antigen, such as B-lymphocytes. Indeed, our latest investigations seem to confirm that B-lymphocytes are weakly involved in rosette formation (data not shown). However, even if these T3~ cells accounted for part of the la + cells observed, they represented at most 46% of rosetting lymphocytes; the rest of the la + cells can only be explained by the presence of activated T-lymphocytes, although no direct argument such as double immunofluorescence staining is provided in this study. The observation that the sum of T4 + and T8 + cells exceeded the percentage of T3 + cells in rosettes from diabetic patients could be due to the implication of a weak number of NK cells that bear the T8 antigen but not the T3 antigen (28) . This could also clear up the finding of a high percentage of T8 + cells in rosettes from control subjects, whereas only 20% of T3 + cells were observed. In conclusion, this immunofluorescence study suggests the major implication of activated T-lymphocytes in diabetic rosettes, whereas these cells are poorly represented in background rosettes.
In contrast, poor involvement of NK cells in the formation of diabetic rosettes is supported by the presence of fewer Leu 11 + cells than in background rosettes. Moreover, lymphocytes of recent-onset type I diabetic subjects showed a tendency to decreased cytoadherence to K562 cells. Finally, NK activity of lymphocytes from recent-onset type I diabetic subjects was significantly lower compared with control subjects and even inversely correlated to their ability to adhere to RIN cells. This contrary correlation between RIN rosettes and NK activity could be due to the simple coexistence of the two phenomena or could reveal a causal relation between them; because NK cells are suspected of being involved in a large natural nonspecific suppressor-cell family that could be responsible for self tolerance (29) , a lack of such natural suppressor cells could lead to autosensitization, as possibly revealed in our model by an increased number of rosetting lymphocytes. In any case, the decreased NK lytic activity of lymphocytes in diabetes is in agreement with a recent publication by Negishi et al. (30) , who show that NK cell cytotoxic activity by enriched non-T-lymphocytes was lowered in recent-onset type I diabetic subjects but unimpaired in type II and type I diabetic patients with long-standing disease. On the other hand, this last finding is contrary to the description of increased NK activity and involvement of these NK cells in (3-cell aggression in vitro (18) and in vivo (31) in the BB/W rat. However, the involvement of other cell types, such as B-lymphocytes or killer cells, along with activated T-lymphocytes, in the formation of diabetic rosettes cannot be excluded by this study. Studies of enrichment or depletion of different lymphocyte subpopulations are being done in our laboratory to determine more precisely which cells are involved in the diabetic rosette phenomenon.
Indeed, despite the suggested importance of cellular immunity against p-cells in the pathogenesis of type I diabetes, studies on this cellular autoimmunity in humans are still few compared with those done in animal models and particularly in the BB/W rat in which transfer of diabetes was achieved by injections of concanavalin A-stimulated lymphocytes (20) . In humans, the diabetogenic role of cellular autoimmunity is supported in vivo by the presence of activated Tlymphocytes (la + , T4 + , or T8 + ) in insulitis, described in a case of death at the onset of diabetes (32) and in rejected pancreatic grafts between monozygotic twins when the recipient was diabetic (33) . This hypothesis is also supported by in vitro demonstration of lymphocytes from diabetic subjects that alter insulin release (17) or even kill islet cells (16) . Finally, the pathogenic role of cellular immunity is strengthened by the ability of cyclosporin A to increase the remission rate in type I diabetes (3) while blocking cellular immunity detected in vitro by the alteration of insulin release (34) . On the other hand, the suggested transfer of diabetes to animals by injections of lymphocytes from human diabetic patients (35) was not confirmed (36) . Although the mechanisms of rosette formation remain to be clarified, this phenomenon could represent a useful marker for further investigation of the involvement of anti-fS-cell cellular immunity in the pathogenesis of type I diabetes.
